Your browser doesn't support javascript.
loading
Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT.
Nagler, Arnon; Labopin, Myriam; Arat, Mutlu; Reményi, Péter; Koc, Yener; Blaise, Didier; Angelucci, Emanuele; Vydra, Jan; Kulagin, Aleksandr; Socié, Gerard; Rovira, Montserrat; Sica, Simona; Aljurf, Mahmoud; Gülbas, Zafer; Kröger, Nicolaus; Brissot, Eolia; Peric, Zinaida; Giebel, Sebastian; Ciceri, Fabio; Mohty, Mohamad.
Afiliação
  • Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Labopin M; Sorbonne Université, INSERM UMR-S 938, CRSA, Service d'hématologie et Thérapie Cellulaire, AP-HP, Hôpital Saint-Antoine, Paris, France.
  • Arat M; European Society for Blood and Marrow Transplantation Paris Study Office/CEREST-TC, Paris, France.
  • Reményi P; Istanbul Florence Nightingale Hospital HSCT Unit, Istanbul, Turkey.
  • Koc Y; Dél-pesti Centrumkórház-Országos Hematológiaiés Infektológiai Intézet, Department of Haematology and Stem Cell Transplant, Budapest, Hungary.
  • Blaise D; Medicana International Hospital Istanbul, Bone MarrowTransplant Unit, Istanbul, Turkey.
  • Angelucci E; Programme de Transplantation and Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
  • Vydra J; Ospedale San Martino, Department of Haematology II, Genoa, Italy.
  • Kulagin A; Institute of Hematology and Blood Transfusion, Servicio de Hematología, Prague, Czech Republic.
  • Socié G; First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation, St. Petersburg, Russia.
  • Rovira M; Hopital St. Louis, Department of Hematology-BMT, Paris, France.
  • Sica S; Hospital Clinic, Department of Hematology, Institute of Hematology and Oncology, Barcelona, Spain.
  • Aljurf M; Universita Cattolica S. Cuore, Istituto di Ematologia, Ematologia, Rome, Italy.
  • Gülbas Z; King Faisal Specialist Hospital and Research Centre, Oncology (Section of Adult Haematolgy/BMT), Riyadh, Saudi Arabia.
  • Kröger N; Anadolu Medical Center Hospital, Bone Marrow Transplantation Department, Kocaeli, Turkey.
  • Brissot E; University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany.
  • Peric Z; Sorbonne Université, INSERM UMR-S 938, CRSA, Service d'hématologie et Thérapie Cellulaire, AP-HP, Hôpital Saint-Antoine, Paris, France.
  • Giebel S; European Society for Blood and Marrow Transplantation Paris Study Office/CEREST-TC, Paris, France.
  • Ciceri F; University of Zagreb School of Medicine, Zagreb, Croatia.
  • Mohty M; Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
Cancer ; 128(22): 3959-3968, 2022 11 15.
Article em En | MEDLINE | ID: mdl-36110063
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies Limite: Adult / Humans Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies Limite: Adult / Humans Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel